Javascript must be enabled to continue!
Excessive Handling as a Cause of Hypoxemia
View through CrossRef
Continuous transcutaneous oxygen (TcPo2) monitoring was used to study low-birth-weight infants (15 control, 15 experimental) during their stay in the intensive care nursery (ICN). Twenty hours of continuous recordings were made of heart rate, respiratory rate, and TcPo2 in the first five days after birth. Personnel caring for the control infants were blind to the TcPo2 measurements. Those caring for the experimental group were instructed in the operation of the TcPo2 monitor and used the device to modify the timing and extent of procedures to minimize "undesirable time" (TcPo2 < 40 or > 100 torr). Control group infants had an average of 40 min/20 hr in "undesirable time." When personnel used TcPo2 monitoring to modify care this "undesirable time" was reduced to 6 min/20 hr. This difference was statistically significant (P < .001). Infants in the control group were handled more frequently, and experienced more hypoxemia. Of the hypoxemic time suffered by the control infants 75% was associated with handling. Only 5% of the hypoxemia or hyperoxemia was detected by blood Pao2 analysis or conventional monitors.
Intermittent arterial blood gas sampling is an inadequate method for monitoring arterial oxygenation in low-birth-weight infants since hypoxemia and hyperoxemia are often missed. Continuous TcPo2 monitoring improves care by diminishing "undesirable time."
American Academy of Pediatrics (AAP)
Title: Excessive Handling as a Cause of Hypoxemia
Description:
Continuous transcutaneous oxygen (TcPo2) monitoring was used to study low-birth-weight infants (15 control, 15 experimental) during their stay in the intensive care nursery (ICN).
Twenty hours of continuous recordings were made of heart rate, respiratory rate, and TcPo2 in the first five days after birth.
Personnel caring for the control infants were blind to the TcPo2 measurements.
Those caring for the experimental group were instructed in the operation of the TcPo2 monitor and used the device to modify the timing and extent of procedures to minimize "undesirable time" (TcPo2 < 40 or > 100 torr).
Control group infants had an average of 40 min/20 hr in "undesirable time.
" When personnel used TcPo2 monitoring to modify care this "undesirable time" was reduced to 6 min/20 hr.
This difference was statistically significant (P < .
001).
Infants in the control group were handled more frequently, and experienced more hypoxemia.
Of the hypoxemic time suffered by the control infants 75% was associated with handling.
Only 5% of the hypoxemia or hyperoxemia was detected by blood Pao2 analysis or conventional monitors.
Intermittent arterial blood gas sampling is an inadequate method for monitoring arterial oxygenation in low-birth-weight infants since hypoxemia and hyperoxemia are often missed.
Continuous TcPo2 monitoring improves care by diminishing "undesirable time.
".
Related Results
Risk factors for intraprocedural hypoxemia in patients with acute cerebral ischemia treated with vascular intervention and its impact on prognosis: A retrospective cohort study
Risk factors for intraprocedural hypoxemia in patients with acute cerebral ischemia treated with vascular intervention and its impact on prognosis: A retrospective cohort study
Abstract:
BACKGROUND:
Acute cerebral infarction (ACI) is one of the most common ischemic cerebrovascular diseases in neurology, with high morbidi...
A Randomized Controlled Trial of Naloxone for Optimization of Hypoxemia in Lung Donors After Brain Death
A Randomized Controlled Trial of Naloxone for Optimization of Hypoxemia in Lung Donors After Brain Death
Background.
Persistent hypoxemia is the principal reason lungs from otherwise eligible brain dead (BD) organ donors are not transplanted. Experimental models and retros...
Overestimation of Oxygen Saturation Measured by Pulse Oximetry in Hypoxemia. Part 1: Effect of Optical Pathlengths-Ratio Increase
Overestimation of Oxygen Saturation Measured by Pulse Oximetry in Hypoxemia. Part 1: Effect of Optical Pathlengths-Ratio Increase
On average, arterial oxygen saturation measured by pulse oximetry (SpO2) is higher in hypoxemia than the true oxygen saturation measured invasively (SaO2), thereby increasing the r...
P4675The utility of additional balloon pulmonary angioplasty for residual hypoxemia in normohemodynamic chronic thromboembolic pulmonary hypertension patients after invasive treatments
P4675The utility of additional balloon pulmonary angioplasty for residual hypoxemia in normohemodynamic chronic thromboembolic pulmonary hypertension patients after invasive treatments
Abstract
Background
Balloon pulmonary angioplasty (BPA) improves hemodynamics, symptoms and exercise capacity in patients with c...
Evaluation of Leading Smartwatches for the Detection of Hypoxemia: Comparison to Reference Oximeter
Evaluation of Leading Smartwatches for the Detection of Hypoxemia: Comparison to Reference Oximeter
Although smartwatches are not considered medical devices, experimental validation of their accuracy in detecting hypoxemia is necessary due to their potential use in monitoring con...
Evaluating Safe Patient Handling Systems: Is There a Better Way?
Evaluating Safe Patient Handling Systems: Is There a Better Way?
<p>The literature presented here shows that injuries suffered by staff and patients due to patient handling are preventable but patient handling injuries to health care worke...
Differential hypoxemia during peripheral cardiopulmonary bypass
Differential hypoxemia during peripheral cardiopulmonary bypass
Introduction
Minimally invasive cardiac surgery (MICS) for mitral valve repair often uses cardiopulmonary bypass (CPB) through peripheral femoro-femoral cannulation. A ...
Brain Weight Effect of Ambrisentan in Juvenile Rat Toxicity Studies Associated With Breathing Sounds, Apnea, and Sustained Hypoxemia
Brain Weight Effect of Ambrisentan in Juvenile Rat Toxicity Studies Associated With Breathing Sounds, Apnea, and Sustained Hypoxemia
ABSTRACTBackgroundAmbrisentan is a selective endothelin‐1 receptor antagonist marketed for pulmonary arterial hypertension (PAH) in adults, adolescents, and children above 8 years ...

